Uddin Ajam, Halder Shimul, Deb Nandita, Das Harinarayan, Shuma Madhabi Lata, Hasan Ikramul, Shill Manik Chandra, Haider Syed Shabbir
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Department of Physics, Faculty of Science, University of Dhaka, Dhaka 1000, Bangladesh.
Adv Pharmacol Pharm Sci. 2024 May 28;2024:2303942. doi: 10.1155/2024/2303942. eCollection 2024.
This study aims to improve the biopharmaceutical, mechanical, and tableting properties of a poorly soluble drug, ibuprofen (IBP), by preparing amorphous solid dispersion (ASD) followed by a sustained-release tablet formulation. A suitable polymer to develop an ASD system was chosen by utilizing the apparent solubility of IBP in various polymer solutions. ASDs containing various ratios of IBP and selected polymer were prepared by the melt fusion (MF) method. ASD containing optimized drug-polymer ratio prepared by freeze-drying (FD) method was characterized and compared physicochemically. The solubility of IBP in water increased 28-fold and 35-fold when formulated as ASD by MF and FD, respectively. Precise formulations showed amorphization of IBP and increased surface area, improving solubility. The dissolution pattern of optimized ASD-IBP in pH 6.8 phosphate buffer after 60 min in MF and FD was enhanced 3-fold. In addition, direct compression tablets comprising optimized ASD granules from MF and FD were made and assessed using compendial and noncompendial methods. ASD-IBP/MF and ASD-IBP/FD formulations showed a similar drug release profile. In addition, 12 h of sustained IBP release from the ASD-IBP-containing tablets was obtained in a phosphate buffer with a pH of 6.8. From the dissolution kinetics analysis, the Weibull model fitted well. The drug release pattern indicated minimal variations between tablets formed using ASD-IBP prepared by both procedures; however, pre- and postcompression assessment parameters differed. From these findings, the application of ASD and sustained-release polymers in matrix formation might be beneficial in improving the solubility and absorption of poorly soluble drugs such as IBP.
本研究旨在通过制备无定形固体分散体(ASD)并随后制成缓释片剂,改善难溶性药物布洛芬(IBP)的生物制药、机械和压片性能。通过利用IBP在各种聚合物溶液中的表观溶解度,选择一种合适的聚合物来开发ASD系统。采用熔融法制备了含有不同比例IBP和所选聚合物的ASD。对通过冷冻干燥(FD)法制备的含有优化药物 - 聚合物比例的ASD进行了表征,并进行了物理化学比较。当分别通过熔融法和冷冻干燥法将IBP制成ASD时,其在水中的溶解度分别提高了28倍和35倍。精确的制剂显示IBP呈无定形且表面积增加,从而提高了溶解度。在熔融法和冷冻干燥法中,优化后的ASD - IBP在pH 6.8磷酸盐缓冲液中60分钟后的溶出模式提高了3倍。此外,制备了包含来自熔融法和冷冻干燥法的优化ASD颗粒的直接压片,并使用药典和非药典方法进行评估。ASD - IBP / MF和ASD - IBP / FD制剂显示出相似的药物释放曲线。此外,在pH为6.8的磷酸盐缓冲液中,含ASD - IBP的片剂实现了12小时的IBP持续释放。从溶出动力学分析来看,威布尔模型拟合良好。药物释放模式表明,使用两种方法制备的ASD - IBP制成的片剂之间差异极小;然而,压片前和压片后的评估参数有所不同。基于这些发现,ASD和缓释聚合物在基质形成中的应用可能有利于改善难溶性药物如IBP的溶解度和吸收。